Media
Welcome to our media library, a collection of our latest releases and features across publications and podcasts.
Big data should have replaced the focus group by now. But it hasn’t. That quaint 20th century practice of getting people to sit around a table and talk about a product is still with us. Marketers still use it to gain insights into why consumers want…
The first anti-cancer biosimilars became available in the Unites States market in 2019. As more patients are either recommended by their provider or financially incentivized by their insurance to use a biosimilar, patients will likely have many questions…
Background: As precision medicine testing and treatment options evolve, the complexity of what patients and caregivers need to understand to be active members of their healthcare team has increased dramatically. Patients and caregivers are overwhelmed and confused…
As precision medicine testing and treatment options evolve, the complexity of what cancer patients and caregivers need to understand to be active members in their health care team has increased dramatically. Patients and caregivers are overwhelmed and confused…
Background As the use of immunotherapy as treatment for cancer patients continues to expand, it is important that patients and caregivers have access to relevant educational and community resources to support them in making informed decisions and receiving optimal…
Background As the use of immunotherapy as treatment for cancer patients continues to expand, it is important that patients and caregivers have access to relevant educational and community resources to support them in making informed decisions and receiving optimal…
Background In 2006, the Cancer Support Community (CSC) launched its Frankly Speaking About Cancer: Metastatic Breast Cancer (MBC) patient education program. This program raises awareness among patients and caregivers about MBC, current treatment options…
Background: The National Cancer Institute estimates more than 20,000 people will be diagnosed and over 163,000 people will be living with chronic lymphocytic leukemia (CLL) in the United States in 2019. In 2017, nearly 40% of CLL patients who participated in the…
Background: The Cancer Support Community (CSC) has designed a patient/provider discussion tool for patients with chronic myeloid leukemia (CML). The main goal of the tool is to help patients and caregivers better communicate with their healthcare providers…
